Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Genetic Studies Uncover Mechanisms Driving Drug Resistance in Superbugs

By LabMedica International staff writers
Posted on 17 Sep 2026

Multidrug-resistant bacterial infections continue to complicate care in hospitals, where transmission can reach patients at greatest risk. More...

As pathogens evade last‑line agents, laboratories face pressure to clarify the genetic and clinical routes that sustain resistance. Understanding how colonization progresses to bloodstream infection during chemotherapy‑related neutropenia is especially important for stewardship. New findings demonstrate complementary molecular and clinical strategies that illuminate resistance in Klebsiella pneumoniae and trace its spread to high‑risk patients.

Hackensack Meridian Center for Discovery and Innovation (CDI; Nutley, NJ, USA) describes three coordinated investigations published in Antimicrobial Agents and Chemotherapy that span genetics, pharmacology, and clinical epidemiology. One study mapped genome‑wide determinants of susceptibility in carbapenem‑resistant Klebsiella pneumoniae using high‑density transposon sequencing (TnSeq). A second defined how pathogens evade cefiderocol, a siderophore cephalosporin that exploits bacterial iron‑uptake channels. A third tracked transmission dynamics in patients undergoing intensive chemotherapy to connect colonization with subsequent bloodstream infection.

In the genetic screen, researchers found that when superbugs alter outer-surface receptors to evade bacteriophages, they incur a trade-off that restores susceptibility to last-line antibiotics, including meropenem, colistin, and cefiderocol. The cefiderocol analysis further identified a multilayered resistance network centered on cell-envelope homeostasis and blaKPC-3 β-lactamases. Deleting blaKPC-3 from resistant strains reduced minimum inhibitory concentrations (MICs) fourfold, suggesting that low intracellular drug levels allow even modest enzyme activity to sustain high-level resistance. Together, these findings identify genetic mechanisms that shape antibiotic susceptibility in ST258 K. pneumoniae.

The prospective clinical study followed 159 adults with acute leukemia or myelodysplastic syndrome during chemotherapy-induced neutropenia. Among patients colonized with extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E), 20% developed bloodstream infections caused by matching strains. Whole-genome sequencing (WGS) confirmed complete concordance between colonizing and bloodstream isolates, supporting targeted screening to inform prophylactic antibiotic use while limiting unnecessary treatment.

All three papers appear in Antimicrobial Agents and Chemotherapy and reflect collaborations with the University at Buffalo and Weill Cornell Medicine alongside CDI scientists. The work integrates molecular genetics with patient‑level surveillance to clarify how resistance emerges and moves from colonization to invasive disease in vulnerable patients, offering laboratory‑grounded insights for antimicrobial stewardship and infection prevention programs.

"These studies collectively show how we are tracking and better understanding the many forms of drug resistance that bacterial pathogens evolve, given the opportunity," said Barry N. Kreiswirth, a member of the CDI and professor at the Hackensack Meridian School of Medicine.

"By bridging molecular genetics, genomics and clinical epidemiology, Kreiswirth and his lab continue to uncover the underlying rules of bacterial survival—which are pointing the way toward better clinical outcomes," said David Perlin, chief scientific officer and executive vice president of the CDI.

Related Links
Hackensack Meridian CDI


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Led by Professor Sherry Chan Kit-wa (middle), the HKUMed research team provides the first large-scale Chinese population evidence to support reviewing Hong Kong’s long-term blood-monitoring requirements for clozapine use. (Photo courtesy of HKUMed)

Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine

Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia for which clozapine remains the only antipsychotic specifically approved by the U.S. Food and Drug Administration (FDA).... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.